tiprankstipranks
Milestone Scientific (MLSS)
NYSE MKT:MLSS
US Market
Holding MLSS?
Track your performance easily

Milestone Scientific (MLSS) Earnings Date & Reports

259 Followers

Earnings Data

Report Date
Apr 07, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-$0.01
Last Year’s EPS
-$0.02
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 14, 2024
|
% Change Since: 17.38%
|
Next Earnings Date:Apr 07, 2025
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant revenue growth in the third quarter, strong gross margins, and strategic progress in the medical division with Medicare Part B alignment. However, concerns remain with the lack of revenue from China and an overall revenue decline over the nine-month period. Despite these challenges, the company seems well-positioned for future growth, particularly in international markets.
Company Guidance
In the Q3 2024 earnings call for Milestone Scientific (MLSS), the company reported a 22% year-over-year revenue increase to $2.5 million, driven by a 57% rise in international dental sales and a successful shift to an e-commerce sales model domestically. Gross margins remained high at 73%. The medical division made progress with the CompuFlo Epidural System, benefiting from a Medicare Part B payment rate assignment across several regions, including New Jersey, Texas, and Florida. The company highlighted a significant market opportunity with 3 million epidural procedures annually in these regions, representing a $250 million market potential. Additionally, the company secured regulatory approval in Brazil, targeting over 2.8 million annual births and a substantial population with chronic back pain, marking a promising growth avenue for the company. Internationally, MLSS is expanding its reach through partnerships with distributors in key markets. The call also noted a 11.4% growth in the U.S. e-commerce dental business over nine months, and the company maintained a strong balance sheet with $4.8 million in cash and no long-term debt.
Significant Revenue Growth
Milestone Scientific achieved a 22% increase in year-over-year revenue, reaching $2.5 million, driven by strong growth in the Dental division and a 57% increase in international dental sales.
Strong Gross Margin
Gross margins remained high at 73%, indicating strong profitability from operations.
Medicare Part B Assignment for CompuFlo
The CompuFlo Epidural System received a Medicare Part B physician payment rate assignment, increasing its adoption in clinics such as Hudson Specialty Care and iHealPain Center.
Expansion into International Markets
Regulatory approval was secured in Brazil for the CompuFlo system, opening a significant market opportunity with over 2.8 million births annually.
Improvement in Operating Loss
Operating loss decreased by $38,000 compared to the previous year, showing financial management improvements.
---

Milestone Scientific (MLSS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MLSS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 07, 20252024 (Q4)
-0.01 / -
-0.02
Nov 14, 20242024 (Q3)
-0.01 / -0.02
-0.020.00% (0.00)
Aug 15, 20242024 (Q2)
-0.01 / 0.00
-0.03
May 16, 20242024 (Q1)
- / -
-0.02
Apr 01, 20242023 (Q4)
-0.02 / -0.02
-0.020.00% (0.00)
Nov 15, 20232023 (Q3)
-0.02 / -0.02
-0.0333.33% (<+0.01)
Aug 15, 20232023 (Q2)
-0.02 / -0.03
-0.0425.00% (+0.01)
May 11, 20232023 (Q1)
- / -
-0.03
Mar 31, 20232022 (Q4)
-0.03 / -0.02
-0.0333.33% (<+0.01)
Nov 15, 20222022 (Q3)
-0.03 / -0.03
-0.030.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

MLSS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 14, 2024$0.68$0.65-4.41%
Aug 15, 2024$1.01$0.98-2.97%
May 16, 2024$0.69$0.68-1.45%
Apr 01, 2024$0.62$0.65+4.84%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Milestone Scientific (MLSS) report earnings?
Milestone Scientific (MLSS) is schdueled to report earning on Apr 07, 2025, TBA Not Confirmed.
    What is Milestone Scientific (MLSS) earnings time?
    Milestone Scientific (MLSS) earnings time is at Apr 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MLSS EPS forecast?
          MLSS EPS forecast for the fiscal quarter 2024 (Q4) is -$0.01.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis